SGYP Synergy Pharmaceuticals Inc.

0.33
+0.03  (+10%)
Previous Close 0.3
Open 0.3
Price To Book -0.85
Market Cap 81827506
Shares 248,037,301
Volume 10,347,157
Short Ratio
Av. Daily Volume 14,165,980

SEC filingsSee all SEC filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19520832
  2. 8-K - Current report 19520539
  3. 8-K - Current report 19502050
  4. 8-K - Current report 181240877
  5. 8-K - Current report 181233906

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced January 25, 2018.
Trulance (plecanatide)
Constipation-predominant irritable bowel syndrome (IBS-C)
Approved January 19, 2017.
Trulance (plecanatide)
Chronic idiopathic constipation (CIC)

SEC Filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19520832
  2. 8-K - Current report 19520539
  3. 8-K - Current report 19502050
  4. 8-K - Current report 181240877
  5. 8-K - Current report 181233906
  6. 8-K - Current report 181221066
  7. 8-K - Current report 181201158
  8. 8-K - Current report 181191183
  9. CT ORDER - Confidential treatment order 181186542
  10. 8-K - Current report 181180332